In aggregate the valuations for the midcap are not too far away from long period averages while small caps are still away from their own mean. But as always there are differences across sectors. I do not see major froth building in a hurry and expect opportunities to be available on a bottom basis across both cohorts for investors looking at the next few quarters.
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO
July 27, 2026